Tekgul Hasan, Yalaz Mehmet, Kutukculer Necil, Ozbek Sureyya, Kose Timur, Akisu Mete, Kultursay Nilgun, Gokben Sarenur
Department of Pediatrics, Division of Pediatric Neurology, Ege University Hospital, Izmir, Turkey.
Pediatr Neurol. 2004 Nov;31(5):326-32. doi: 10.1016/j.pediatrneurol.2004.05.004.
The aim of this study was to define the predictive values of serum and cerebrospinal fluid concentrations of interleukin-6 and neuron-specific enolase and urinary uric acid/creatinine ratio for outcome in term infants with perinatal asphyxia. All biochemical markers were measured simultaneously within the 24-72 hours of life in 21 infants. The infants were monitored with a standardized neurologic and developmental evaluation protocol over the 2 years of life. The overall outcome at 2 years of age was categorized as "favorable" or "adverse". According to Sarnat and Sarnat classification, 12 infants had mild encephalopathy and 9 infants had moderate to severe encephalopathy. Seven of 9 (78%) infants with moderate to severe encephalopathy had adverse outcome. However, all infants with mild encephalopathy had favorable outcome. Interleukin-6 and neuron specific enolase levels in cerebrospinal fluid and serum interleukin-6 levels were significantly correlated with the degree of encephalopathy, as well as the outcome. Interleukin-6 in cerebrospinal fluid (cutoff value, 25.9 pg/mL) had the highest predictive value among the biochemical markers. The predictive factors identified in this study should be examined for their ability in a fresh clinical sample in the neonatal intensive care unit before these markers can be applied to the routine clinical of infants with perinatal asphyxia.
本研究的目的是确定围产期窒息足月儿血清和脑脊液中白细胞介素-6及神经元特异性烯醇化酶的浓度以及尿尿酸/肌酐比值对预后的预测价值。对21例婴儿在出生后24至72小时内同时检测了所有生化指标。在婴儿2年的生命过程中,采用标准化的神经学和发育评估方案对其进行监测。2岁时的总体预后分为“良好”或“不良”。根据萨纳特和萨纳特分类法,12例婴儿患有轻度脑病,9例婴儿患有中度至重度脑病。9例中度至重度脑病婴儿中有7例(78%)预后不良。然而,所有轻度脑病婴儿预后均良好。脑脊液中的白细胞介素-6和神经元特异性烯醇化酶水平以及血清白细胞介素-6水平与脑病程度及预后均显著相关。脑脊液中的白细胞介素-6(临界值为25.9 pg/mL)在生化指标中具有最高的预测价值。在这些标志物可应用于围产期窒息婴儿的常规临床治疗之前,应在新生儿重症监护病房的新鲜临床样本中检验本研究确定的预测因素的能力。